These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 343907)

  • 21. Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma.
    Porcile G; Musso M; Boccardo F; Rosso R; Santi L
    Tumori; 1979 Apr; 65(2):237-40. PubMed ID: 88784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophosphamide, adriamycin, and DTIC polychemotherapy in advanced small cell lung cancer.
    Saiontz HI; Dalton RJ; Eagan RT
    Cancer Treat Rep; 1977; 61(3):481-3. PubMed ID: 194692
    [No Abstract]   [Full Text] [Related]  

  • 23. Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice.
    Fodstad O; Aass N; Pihl A
    Int J Cancer; 1980 Apr; 25(4):453-8. PubMed ID: 7372371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials.
    Huncharek M; Caubet JF; McGarry R
    Melanoma Res; 2001 Feb; 11(1):75-81. PubMed ID: 11254118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma.
    Samson MK; Baker LH; Izbicki RM; Ratanatharathorn V
    Cancer Treat Rep; 1976 Sep; 60(9):1369-71. PubMed ID: 65223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclophosphamide, vincristine and procarbazine in the treatment of malignant melanoma.
    Byrne MJ
    Cancer; 1976 Nov; 38(5):1922-4. PubMed ID: 791477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [DTIC in the therapy of solid tumours (author's transl)].
    Kokron O; Pridun N; Zischinsky W
    Wien Klin Wochenschr; 1978 Dec; 90(24):864-7. PubMed ID: 741753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma.
    Ahmann DL; Bisel HF; Edmonson JH; Hahn RG; Eagan RT; O'Connell MJ; Frytak S
    Clin Pharmacol Ther; 1976 Jun; 19(6):821-4. PubMed ID: 773589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study.
    Friedman MA; Kaufman DA; Williams JE; Resser KJ; Rosenbaum EH; Cohen RJ; Glassberg AB; Blume MR; Gershow J; Chan EY
    Cancer Treat Rep; 1979 Mar; 63(3):493-5. PubMed ID: 371802
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).
    Hill GJ; Ruess R; Berris R; Philpott GW; Parkin P
    Ann Surg; 1974 Aug; 180(2):167-74. PubMed ID: 4601984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
    Rudolf Z; Strojan P
    Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
    Ahmann DL; Edmonson JH; Frytak S; Kvols LK; Bisel HF; Rubin J
    Cancer Treat Rep; 1978 Jan; 62(1):151-3. PubMed ID: 626995
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dacarbacine (DTIC) in the therapy of a malignant disease. A review (author's transl)].
    Huber H; Grünewald K
    Wien Klin Wochenschr; 1978 Dec; 90(24):861-4. PubMed ID: 369151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.
    Gottlieb JA; Benjamin RS; Baker LH; O'Bryan RM; Sinkovics JG; Hoogstraten B; Quagliana JM; Rivkin SE; Bodey GP; Rodriguez V; Blumenschein GR; Saiki JH; Coltman C; Burgess MA; Sullivan P; Thigpen T; Bottomley R; Balcerzak S; Moon TE
    Cancer Treat Rep; 1976 Feb; 60(2):199-203. PubMed ID: 769974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of metastatic malignant melanoma (author's transl)].
    Kühböck J; Pehamberger H; Mach K; Diem E; Kokoschka EM; Pötzi P
    Wien Klin Wochenschr; 1978 Dec; 90(24):856-8. PubMed ID: 84441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
    Thatcher D; Lind M; Morgenstern G; Carr T; Chadwick G; Jones R; Craig P
    Cancer; 1989 Apr; 63(7):1296-302. PubMed ID: 2646005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy in disseminated melanoma and other solid tumors in adults.
    Gerner RE; Moore GE; Dickey C
    Oncology; 1975; 31(1):22-30. PubMed ID: 1099501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe myelosuppression from piperazinedione, (NSC No. 135758), cyclophosphamide plus dimethyl-triazeno-imidazole carboxamide (DTIC).
    Presant CA; Klahr C
    Cancer; 1977 Oct; 40(4):1386-9. PubMed ID: 907959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
    McKelvey EM; Luce JK; Talley RW; Hersh EM; Hewlett JS; Moon TE
    Cancer; 1977 Jan; 39(1):1-4. PubMed ID: 832224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of metastatic malignant melanoma.
    Atallah E; Flaherty L
    Curr Treat Options Oncol; 2005 May; 6(3):185-93. PubMed ID: 15869730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.